Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Airway Obstruction D000402 13 associated lipids
Uremia D014511 33 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Graft Occlusion, Vascular D006083 11 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Adenocarcinoma D000230 166 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Snapper JR et al. Effects of platelet depletion on the unanesthetized sheep's pulmonary response to endotoxemia. 1984 J. Clin. Invest. pmid:6501570
Irvine RF et al. One-dimensional thin-layer chromatographic separation of the lipids involved in arachidonic acid metabolism. 1984 J Pharmacol Methods pmid:6443136
Huval WV et al. Role of serotonin in patients with acute respiratory failure. 1984 Ann. Surg. pmid:6547816
Croft KD et al. Dietary modification of fatty acid and prostaglandin synthesis in the rat. Effect of variations in the level of dietary fat. 1984 Biochim. Biophys. Acta pmid:6548159
Wada H et al. Effect of TEI-4120 (3-benzoyl-N-beta-ethoxyisopropyl-2-methlindole) on carrageenan induced disseminated intravascular coagulation (DIC) in rats. 1984 J. Pharmacobio-dyn. pmid:6548260
Welton AF et al. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases. 1984 J. Pharmacol. Exp. Ther. pmid:6198511
Runkle B et al. Cardiovascular changes in group B streptococcal sepsis in the piglet: response to indomethacin and relationship to prostacyclin and thromboxane A2. 1984 Pediatr. Res. pmid:6384909
Stegmeier K et al. The pharmacological profile of the thromboxane A2 antagonist BM 13.177. A new anti-platelet and anti-thrombotic drug. 1984 Thromb. Res. pmid:6385334
Ritter JM Prostanoid synthesis by aortic rings in human blood: selective increase of prostacyclin mediated by a serum factor. 1984 Br. J. Pharmacol. pmid:6386089
Sekiya K and Okuda H Inhibitory action of soluble elastin on thromboxane B2 formation in blood platelets. 1984 Biochim. Biophys. Acta pmid:6320905
Keinänen-Kiukaanniemi S et al. Decreased thromboxane production in migraine patients during headache-free period. 1984 Headache pmid:6519984
Uehara Y et al. [A solid phase direct radioimmunoassay for urinary thromboxane B2 and its clinical application]. 1984 Nihon Jinzo Gakkai Shi pmid:6527429
Wang JP et al. Antiplatelet effect of capsaicin. 1984 Thromb. Res. pmid:6528310
Robson MC et al. A new explanation for the progressive tissue loss in electrical injuries. 1984 Plast. Reconstr. Surg. pmid:6422484
Lampugnani MG and de Gaetano G Effects of metabolized and unmetabolized arachidonate on rat platelet shape change. 1984 Am. J. Physiol. pmid:6433724
Stuart MJ et al. Differences in thromboxane production between neonatal and adult platelets in response to arachidonic acid and epinephrine. 1984 Pediatr. Res. pmid:6435080
Shohami E and Sidi A Accumulation of prostacyclin in rat brain during haemorrhagic hypotension--possible role of PGI2 in autoregulation. 1984 J. Cereb. Blood Flow Metab. pmid:6363432
Worthington RE and Fuller GC Dibutyryl cyclic guanosine monophosphate elevates bovine endothelial cell thromboxane production without affecting prostacyclin metabolism. 1984 Thromb. Res. pmid:6322377
Holgate ST and Robinson C 6,9-deepoxy-6,9-(phenylimino)-delta 6,8-Prostaglandin I1, (U-60,257) stimulates prostaglandin D2 and inhibits thromboxane B2 release from ionophore challenged human dispersed lung cells. 1984 Br. J. Pharmacol. pmid:6439267
DeRubertis FR et al. Bile salt stimulation of colonic epithelial proliferation. Evidence for involvement of lipoxygenase products. 1984 J. Clin. Invest. pmid:6438153
Axelrod L and Cornelius P Plasma prostaglandin levels and circulating fuel levels in rats with diabetic ketoacidosis: effects of cyclooxygenase inhibitors and of alpha and beta adrenergic blockade. 1984 Prostaglandins pmid:6440213
Yarom R et al. The effect of T-2 toxin on human platelets. 1984 Toxicol. Appl. Pharmacol. pmid:6710522
Walenga RW et al. Recovery of megakaryocyte thromboxane production in vitro after aspirin inhibition. 1984 Biochem. Biophys. Res. Commun. pmid:6712680
Zipser RD and Smorlesi C Regulation of urinary thromboxane B2 in man: influence of urinary flow rate and tubular transport. 1984 Prostaglandins pmid:6718753
Rehr RB et al. Mechanism of nitroglycerin-induced coronary dilatation: lack of relation to intracoronary thromboxane concentrations. 1984 Am. J. Cardiol. pmid:6437206
Tremoli E et al. Increased platelet sensitivity and thromboxane B2 formation in type-II hyperlipoproteinaemic patients. 1984 Eur. J. Clin. Invest. pmid:6437830
Marks JG et al. Contact urticaria and airway obstruction from carbonless copy paper. 1984 Aug 24-31 JAMA pmid:6235381
MacNab MW et al. The effects of a new thromboxane synthetase inhibitor, CGS-13080, in man. 1984 Feb-Mar J Clin Pharmacol pmid:6371062
Buchanan MR and Hirsh J Effect of aspirin and salicylate on platelet-vessel wall interactions in rabbits. 1984 Jul-Aug Arteriosclerosis pmid:6380468
Paajanen H et al. Modification of platelet aggregation and thromboxane synthesis by intravascular contrast media. 1984 Jul-Aug Invest Radiol pmid:6434489
De Caterina R et al. Thromboxane-B2 generation during ex-vivo platelet aggregation. 1984 Jul-Sep J. Nucl. Med. Allied Sci. pmid:6530623
Egg D Concentrations of prostaglandins D2, E2, F2 alpha, 6-keto-F1 alpha and thromboxane B2 in synovial fluid from patients with inflammatory joint disorders and osteoarthritis. 1984 Mar-Apr Z Rheumatol pmid:6730731
Tanabe M et al. Inhibition of coronary circulatory failure and thromboxane A2 release during coronary occlusion and reperfusion by 2-phenylaminoadenosine (CV-1808) in anesthetized dogs. 1984 May-Jun J. Cardiovasc. Pharmacol. pmid:6202970
Laustiola K et al. Exercise-induced increase in plasma arachidonic acid and thromboxane B2 in healthy men: effect of beta-adrenergic blockade. 1984 May-Jun J. Cardiovasc. Pharmacol. pmid:6202971
Sturm M et al. The measurement of plasma thromboxane B2 and the effect of smoking. 1984 Nov-Dec Clin. Exp. Pharmacol. Physiol. pmid:6536421
Menitove JE et al. Use of prostacyclin to inhibit activation of platelets during preparation of platelet concentrates. 1984 Nov-Dec Transfusion pmid:6390814
Fisher M et al. Selective thromboxane inhibition: a new approach to antiplatelet therapy. 1984 Sep-Oct Stroke pmid:6474531
Uderman HD et al. Thromboxane synthetase inhibitor UK38,485 lowers blood pressure in the adult spontaneously hypertensive rat. 1984 Sep-Oct J. Cardiovasc. Pharmacol. pmid:6209508
Greer IA et al. Inhibition of thromboxane and prostacyclin production in whole blood by adrenoceptor antagonists. 1985 Prostaglandins Leukot Med pmid:2865745
Mikhailidis DP et al. The effect of non-specific beta-blockade on metabolic and haemostatic variables during hypoglycaemia. 1985 Diabetes Res. pmid:2866057
Gragnoli G et al. Effects of somatostatin on the behaviour of thromboxane B2 and beta-thromboglobulin in type I diabetes. 1985 Acta Endocrinol. pmid:2408435
Hänsch GM et al. Induction of prostanoid synthesis in human platelets by the late complement components C5b-9 and channel forming antibiotic nystatin: inhibition of the reacylation of liberated arachidonic acid. 1985 J. Immunol. pmid:2409145
Fiedler VB et al. Leukotrienes on porcine hemodynamics and prostanoid release. 1985 Int. J. Cardiol. pmid:2993176
Boraschi D et al. Regulation of arachidonic acid metabolism in macrophages by immune and nonimmune interferons. 1985 J. Immunol. pmid:3923110
Quilley J and McGiff JC Arachidonic acid metabolism and urinary excretion of prostaglandins and thromboxane in rats with experimental diabetes mellitus. 1985 J. Pharmacol. Exp. Ther. pmid:3925127
Packham MA et al. Duration of the effect of aspirin on the synthesis of thromboxane by density subpopulations of rabbit platelets stimulated with thrombin. 1985 Blood pmid:3926022
Cattaneo M et al. Human platelet aggregation and release reaction induced by platelet activating factor (PAF-acether)--effects of acetylsalicylic acid and external ionized calcium. 1985 Thromb. Haemost. pmid:3927505
Mobley A and Tai HH Synergistic stimulation of thromboxane biosynthesis by calcium ionophore and phorbol ester or thrombin in human platelets. 1985 Biochem. Biophys. Res. Commun. pmid:3927908
Jakubowski JA et al. Cumulative antiplatelet effect of low-dose enteric coated aspirin. 1985 Br. J. Haematol. pmid:3927970
Mehta J et al. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides. 1985 J. Lab. Clin. Med. pmid:3928780
Callahan KS et al. Enhancement of the antiaggregatory activity of prostacyclin by propranolol in human platelets. 1985 Circulation pmid:2986877
Sawada M et al. Enzyme-immunoassay of thromboxane B2 at the picogram level. 1985 Prostaglandins pmid:3929333
Apprill P et al. Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase, serotonin receptors, and alpha-adrenergic receptors. 1985 Circulation pmid:2988822
Fukuda Y [Plasma prostaglandin and thromboxane levels in asthmatic children]. 1985 Arerugi pmid:2992423
Honda M et al. Effects of purified hog pancreatic kallikrein on the kinin-prostaglandin system and renin-angiotensin-aldosterone system. 1985 Nephron pmid:2993934
Mehta P et al. Plasma concentrations of thromboxane and prostacyclin metabolites in patients with bone tumors. 1985 Am J Pediatr Hematol Oncol pmid:2994511
Wilson TW and Tan LK Low plasma renin activity in diabetes. Relation to urine prostaglandin excretion. 1985 Diabetes pmid:3881302
Longenecker GL et al. Kinetics of ibuprofen effect on platelet and endothelial prostanoid release. 1985 Clin. Pharmacol. Ther. pmid:3882308
Mitchell JA et al. Effects of high frequency oscillatory ventilation compared to conventional ventilation upon pulmonary vascular prostanoid production in neonatal piglets. 1985 Prostaglandins Leukot Med pmid:3883366
Wang JP et al. Antiplatelet effect of hsien-ho-t'sao (Agrimonia pilosa). 1985 Am. J. Chin. Med. pmid:3927704
Wenger H et al. Pulmonary dysfunction secondary to soft-tissue endotoxin. 1985 Arch Surg pmid:3883949
Hashimoto Y et al. Time-dependent inhibition of the cyclooxygenase pathway by 12-hydroperoxy-5,8,10,14-eicosatetraenoic acid. 1985 Biochem. Biophys. Res. Commun. pmid:3927909
Howes EL et al. Lipopolysaccharide tolerance inhibits eye inflammation. I. Reduced immune complex or lipopolysaccharide effects. 1985 Arch. Ophthalmol. pmid:3156578
Meyrick B et al. Endothelial prostacyclin production is a late event in granulocyte migration into bovine pulmonary artery intimal explants. 1985 Blood pmid:3904871
Paajanen H and Kormano M Prostacyclin (PGI2) and thromboxane (TXA2) levels during intravenous contrast medium administration in CT. 1985 Eur J Radiol pmid:3896802
Yui Y et al. A new stable prostacyclin analogue OP41483 (15-cyclopentyl-omega-pentanor-5(E)-carbacyclin). 1985 Jpn. Circ. J. pmid:3897597
Túri S et al. [Changes in serum prostaglandin metabolites in Schönlein-Henoch purpura]. 1985 Orv Hetil pmid:3897944
Farias LR et al. Effect of prostaglandin blockers on ascites fluid in pancreatitis. 1985 Surgery pmid:3898455
Kubo K and Kobayashi T Effects of OKY-046, a selective thromboxane synthetase inhibitor, on endotoxin-induced lung injury in unanesthetized sheep. 1985 Am. Rev. Respir. Dis. pmid:3898941
Barst RJ and Stalcup SA Endothelial function in clinical pulmonary hypertension. 1985 Chest pmid:3899537
Pediconi M et al. Effects of acute and chronic ethanol administration on thromboxane and prostacyclin levels and release in rat brain cortex. 1985 Prostaglandins pmid:3901122
Barst RJ et al. Relation of arachidonate metabolites to abnormal control of the pulmonary circulation in a child. 1985 Am. Rev. Respir. Dis. pmid:3917630
De Caterina R et al. Inhibition of platelet aggregation and thromboxane B2 production during aspirin treatment: dependence on the dose of the aggregating agent. 1985 Thromb. Res. pmid:3975876
Cook JA et al. Exchange transfusions in rats with a perfluorated blood substitute: effect on thromboxane B2 levels during endotoxemia. 1985 Circ. Shock pmid:3978769
Reines HD et al. Dazoxiben in human sepsis and adult respiratory distress syndrome. 1985 Clin. Pharmacol. Ther. pmid:3979000
Greco NJ et al. Action of platelet-activating factor on type 1 diabetic human platelets. 1985 J. Lab. Clin. Med. pmid:3981054
Patterson GA et al. Effects of imidazole and indomethacin on fluid balance in isolated sheep lungs. 1985 J. Appl. Physiol. pmid:3884582
Schrör K et al. [Inhibition of platelet aggregation and thromboxane formation by the calcium antagonist nisoldipine following a single oral dose of 10 mg. A double-blind study in healthy probands]. 1985 Klin. Wochenschr. pmid:3838352
Bult H et al. Modification of endotoxin-induced haemodynamic and haematological changes in the rabbit by methylprednisolone, F(ab')2 fragments and rosmarinic acid. 1985 Br. J. Pharmacol. pmid:3838489
Prosdocimi M et al. Coronary and systemic 6-ketoprostaglandin F1 alpha and thromboxane B2 during myocardial ischemia in dog. 1985 Am. J. Physiol. pmid:3838623
Krieger BP et al. Mechanisms of interaction between oxygen and granulocytes in hyperoxic lung injury. 1985 J. Appl. Physiol. pmid:3838744
Bergqvist D et al. The effect of inhibition of thromboxane synthesis in experimental thrombosis and hemostasis. 1985 Thromb. Res. pmid:3838828
Stuart MJ et al. Prostanoids in hemolytic uremic syndrome. 1985 J. Pediatr. pmid:3839015
Yamaguchi A et al. Effect of cetiedil on platelet aggregation and thromboxane synthesis. 1985 Thromb. Res. pmid:2986312
Mendieta CF et al. Biosynthesis of prostaglandins in gingiva of patients with chronic periodontitis. 1985 J. Periodontol. pmid:3919173
Haurand M and Ullrich V Isolation and characterization of thromboxane synthase from human platelets as a cytochrome P-450 enzyme. 1985 J. Biol. Chem. pmid:2999104
Chang J et al. Modulation by hydroxyeicosatetraenoic acids (HETEs) of arachidonic acid metabolism in mouse resident peritoneal macrophages. 1985 Eur. J. Pharmacol. pmid:3920057
Wargovich T et al. Reduction in blood flow in normal and narrowed coronary arteries of dogs by leukotriene C4. 1985 J. Am. Coll. Cardiol. pmid:4045029
Cerletti C et al. Aspirin kinetics and inhibition of platelet thromboxane generation-relevance for a solution of the "aspirin dilemma". 1985 Thromb. Haemost. pmid:4049312
Dejana E et al. Differential salicylate-aspirin interaction on vascular prostacyclin and platelet thromboxane synthesis in patients undergoing saphenectomy. 1985 Proc. Soc. Exp. Biol. Med. pmid:3841210
Hillbom M et al. Platelet thromboxane formation and bleeding time is influenced by ethanol withdrawal but not by cigarette smoking. 1985 Thromb. Haemost. pmid:4049313
Fiedler VB et al. The effects of nafazatrom in an acute occlusion-reperfusion model of canine myocardial injury. 1985 Naunyn Schmiedebergs Arch. Pharmacol. pmid:3841382
Aviram M et al. Plasma lipoproteins affect platelet malondialdehyde and thromboxane B2 production. 1985 Biochem Med pmid:4052061
Simmet T et al. Modulation of eicosanoid release from anaphylactic guinea-pig heart with 5-benzoyl-a-methyl-2-thiophene acetic acid (tiaprofenic acid). 1985 Arch Int Pharmacodyn Ther pmid:3841634
Rinaldo JE and Dauber JH Effect of methylprednisolone and of ibuprofen, a nonsteroidal antiinflammatory agent, on bronchoalveolar inflammation following endotoxemia. 1985 Circ. Shock pmid:4053294
Shingu T [Prostaglandin metabolism in ischemic brain edema]. 1985 Nihon Geka Hokan pmid:3841635
Shohami E and Gross J An ex vivo method for evaluating prostaglandin synthetase activity in cortical slices of mouse brain. 1985 J. Neurochem. pmid:3923156
Tobian L et al. Prostaglandin alterations in barely hypertensive Dahl S rats. 1985 Trans. Assoc. Am. Physicians pmid:3842205
Numano F et al. Coronary spasm, prostaglandin and HLA factors. 1985 Jpn. Circ. J. pmid:3855470
Sterk PJ et al. Limited maximal airway narrowing in nonasthmatic subjects. Role of neural control and prostaglandin release. 1985 Am. Rev. Respir. Dis. pmid:2864892